Senate reform bill may lack clout
This article was originally published in Clinica
Executive Summary
Senator Nancy Kassebaum (R-KS), author of the FDA Performance and Accountability Act, does not intend to seek re-election next November. She stresses her intention to shepherd FDA reform, as chairman of the Labour & Human Resources Committee, through the Senate, but - as a "lame duck" - her power over legislation could be greatly impaired.